In particular, IL-21 appears to be a promising biomarker for differentiating between gingivitis and periodontitis, and is worthy of further well-structured randomized controlled trial-based research to develop it as a discriminatory marker for the early detection of periodontal disease conditions. Here, IL21 is linked to gingivitis.